Lobie P E, Breipohl W, Lincoln D T, García-Aragón J, Waters M J
Department of Physiology and Pharmacology, University of Queensland, St Lucia, Australia.
J Endocrinol. 1990 Sep;126(3):467-71. doi: 10.1677/joe.0.1260467.
Acromegaly is characterized by coarsening of facial features, acanthosis nigricans, hypertrichosis and oily skin. To determine the site through which GH exerts these effects, we have used immunohistochemistry to localize the GH receptor/binding protein (BP) in rat, rabbit and human skin. Three monoclonal antibodies (MAb 1, 43, 263) were immunoreactive in identical locations, whereas no immunoreactivity was evident when control monoclonal antibodies (MAb 50.8 and MAb 7 (rat] were used. Skin from neonatal and adult animals was used to determine whether GH receptor/BP expression was developmentally regulated. Immunoreactivity of the GH receptor/BP in the three species was consistently localized in the stratum basale and stratum spinosum. Intermittent staining was observed in the stratum granulosum. Scattered basal epidermal cells often displayed more intense immunoreactivity. This distribution was observed at all maturational stages examined. Intense GH receptor/BP immunoreactivity was observed in all histological layers of the lower one-third of hair follicles and in hair matrix cells of the dermal papillae. Immunoreactivity was also detected in the outer epithelial root sheath of the upper two-thirds of hair follicles, in sebaceous glands and in fibroblasts of the connective tissue sheath surrounding the follicle. GH receptor/BP immunoreactivity was also present in the secretory duct and myoepithelial cells of human eccrine sweat glands. Fibroblasts, Schwann cells of peripheral nerve fascicles, skeletal muscle cells and adipocytes of the dermis were also immunoreactive as were medial smooth muscle and endothelial cells of arteries. These results provide evidence that GH acts locally on the epidermis and epidermal appendages concordant with our recent localization of GH receptor/BP to epithelial cell types of the gastrointestinal and reproductive systems.
肢端肥大症的特征为面部特征变粗、黑棘皮症、多毛症和皮肤油腻。为了确定生长激素发挥这些作用的部位,我们采用免疫组织化学方法在大鼠、兔和人皮肤中定位生长激素受体/结合蛋白(BP)。三种单克隆抗体(单克隆抗体1、43、263)在相同位置具有免疫反应性,而使用对照单克隆抗体(大鼠的单克隆抗体50.8和单克隆抗体7)时未观察到明显的免疫反应性。使用新生动物和成年动物的皮肤来确定生长激素受体/BP的表达是否受发育调控。生长激素受体/BP在这三个物种中的免疫反应性始终定位于基底层和棘层。在颗粒层观察到间歇性染色。散在的基底表皮细胞通常显示出更强的免疫反应性。在所有检查的成熟阶段均观察到这种分布。在毛囊下三分之一的所有组织学层以及真皮乳头的毛基质细胞中观察到强烈的生长激素受体/BP免疫反应性。在毛囊上三分之二的外上皮根鞘、皮脂腺以及围绕毛囊的结缔组织鞘的成纤维细胞中也检测到免疫反应性。生长激素受体/BP免疫反应性也存在于人类小汗腺的分泌导管和肌上皮细胞中。真皮中的成纤维细胞、周围神经束的施万细胞、骨骼肌细胞和脂肪细胞以及动脉的中层平滑肌和内皮细胞也具有免疫反应性。这些结果提供了证据,表明生长激素在表皮和表皮附属器上局部起作用,这与我们最近将生长激素受体/BP定位于胃肠道和生殖系统的上皮细胞类型一致。